Schonfeld Strategic Advisors »

Tarsus Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 180k 20.25
2023-09-30 $4.3M 244k 17.77

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Tarsus Pharmaceuticals

Cormorant Asset Management
Tang Capital Management
Cowen And Company
Frazier Life Sciences Management
Vanguard Group
Jennison Associates
Perceptive Advisors
Paradigm Biocapital Advisors
Polygon Management
Ikarian Capital
Vivo Capital
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Nantahala Capital Management
Bank of America Corporation

View all funds holding Tarsus Pharmaceuticals